29 May 2023 , 10:37 AM
Result date: 30th May, 2023
Recommendation: Buy
Target price: Rs. 5,150
Analysts at IIFL Capital Services expect Apollo Hospitals Enterprise (Apollo) to witness a sequential improvement of 150-200 basis points in patient occupancies. The company’s revenue could grow 19% over the year-ago quarter and decline 1% sequentially.
Apollo’s EBITDA losses for 24/7 are likely to remain flat sequentially at Rs. 1.9 billion. Overall EBITDA could inch up 3% over the year-ago quarter, even as they could dip 5% on a sequential basis.
Profit After Tax (PAT) could grow 69% over the year ago quarter and decline 3% on a sequential basis.
Important management insights to watch out for:
| March 2023 estimates | YoY change | QoQ change | |
| Revenue (Rs. mn) | 42,317 | 19% | (1)% | 
| EBITDA (Rs. mn) | 4,791 | 3% | (5)% | 
| EBITDA margin (%) | 11.3% | (174) bps | (53) bps | 
| Profit After Tax (Rs. mn) | 1,523 | 69% | (3)% | 
Source: IIFL Research
Related Tags









 IIFL Customer Care Number
 IIFL Customer Care Number 
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000  / 7039-050-000
 IIFL Capital Services Support WhatsApp Number
 IIFL Capital Services Support WhatsApp Number
+91 9892691696


IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.